Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1985 1
1987 1
1990 2
1991 3
1993 1
1995 1
1996 1
1998 1
1999 2
2002 2
2004 1
2005 3
2006 6
2007 7
2008 5
2009 6
2010 5
2011 10
2012 4
2013 9
2014 6
2015 9
2016 7
2017 4
2018 4
2019 8
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Results by year
Filters applied: . Clear all
Page 1
Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Kumar S, Mehta K. Kumar S, et al. Amino Acids. 2013 Jan;44(1):81-8. doi: 10.1007/s00726-011-1139-0. Epub 2011 Nov 15. Amino Acids. 2013. PMID: 22083892 Review.
Despite significant advances in surgery and biology, cancer remains a major health problem. It is now well accepted that metastasis and cancer cells' acquired or inherent resistance to conventional therapies are major roadblocks to successful treatment. ...According to the …
Despite significant advances in surgery and biology, cancer remains a major health problem. It is now well accepted that metastasis a …
Inhibitors of tissue transglutaminase.
Keillor JW, Apperley KY, Akbar A. Keillor JW, et al. Trends Pharmacol Sci. 2015 Jan;36(1):32-40. doi: 10.1016/j.tips.2014.10.014. Epub 2014 Dec 12. Trends Pharmacol Sci. 2015. PMID: 25500711 Review.
Although TG2 is essential for the stabilization of the extracellular matrix, its unregulated activity has been implicated in celiac disease, fibrosis, and cancer metastasis, among other disorders. Given the importance and range of TG2-related pathologies, recent work has f …
Although TG2 is essential for the stabilization of the extracellular matrix, its unregulated activity has been implicated in celiac disease, …
Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Bagatur Y, Ilter Akulke AZ, Bihorac A, Erdem M, Telci D. Bagatur Y, et al. Cell Adh Migr. 2018 Mar 4;12(2):138-151. doi: 10.1080/19336918.2017.1322255. Epub 2017 Jul 14. Cell Adh Migr. 2018. PMID: 28498731 Free PMC article.
We have previously showed the association of TG2 upregulation with progression and metastasis of renal cell carcinoma (RCC) and low disease-free survival. ...
We have previously showed the association of TG2 upregulation with progression and metastasis of renal cell carcinoma (RCC) and low d …
Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A, Mehta K. Verma A, et al. Drug Resist Updat. 2007 Aug-Oct;10(4-5):144-51. doi: 10.1016/j.drup.2007.06.002. Epub 2007 Jul 27. Drug Resist Updat. 2007. PMID: 17662645 Review.
Drug resistance and metastasis are major impediments for the successful treatment of cancer. ...This review discusses the current thinking and implications of increased TG2 expression in development of drug resistance and metastasis by cancer cells....
Drug resistance and metastasis are major impediments for the successful treatment of cancer. ...This review discusses the current thi …
Tissue transglutaminase promotes or suppresses tumors depending on cell context.
Chhabra A, Verma A, Mehta K. Chhabra A, et al. Anticancer Res. 2009 Jun;29(6):1909-19. Anticancer Res. 2009. PMID: 19528447 Free article. Review.
Therefore, elucidation of tumor-encoded genes whose expression contribute to the development of drug resistance and metastasis can be of great significance in revealing novel therapeutic targets for the effective control and treatment of cancer. ...In this review, the cont …
Therefore, elucidation of tumor-encoded genes whose expression contribute to the development of drug resistance and metastasis can be …
Cellular functions of tissue transglutaminase.
Nurminskaya MV, Belkin AM. Nurminskaya MV, et al. Int Rev Cell Mol Biol. 2012;294:1-97. doi: 10.1016/B978-0-12-394305-7.00001-X. Int Rev Cell Mol Biol. 2012. PMID: 22364871 Free PMC article. Review.
In turn, the impact of TG2 on these processes implicates this protein in various physiological responses and pathological states, contributing to wound healing, inflammation, autoimmunity, neurodegeneration, vascular remodeling, tumor growth and metastasis, and tissue fibr …
In turn, the impact of TG2 on these processes implicates this protein in various physiological responses and pathological states, contributi …
Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions.
Bergamini CM, Griffin M, Pansini FS. Bergamini CM, et al. Curr Med Chem. 2005;12(20):2357-72. doi: 10.2174/0929867054864804. Curr Med Chem. 2005. PMID: 16181137 Review.
On the clinical side, these properties are relevant in vascular inflammatory processes, atherosclerosis and tumor metastasis. We summarise the large body of evidence available in this perspective and discuss its implications for the development of new therapeutic strategie …
On the clinical side, these properties are relevant in vascular inflammatory processes, atherosclerosis and tumor metastasis. We summ …
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.
Nezir AE, Ulukan B, Telci D. Nezir AE, et al. Med Sci (Basel). 2019 Feb 6;7(2):24. doi: 10.3390/medsci7020024. Med Sci (Basel). 2019. PMID: 30736384 Free PMC article. Review.
Von Hippel-Lindau mutations leading to the subsequent activation of Hypoxia Inducible Factor (HIF)-1-mediated signaling pathways, survival signaling via the PI3K/Akt pathway resulting in Epithelial Mesenchymal Transition (EMT) metastasis and angiogenesis are the main facto …
Von Hippel-Lindau mutations leading to the subsequent activation of Hypoxia Inducible Factor (HIF)-1-mediated signaling pathways, survival s …
96 results